The Daily Mail:
UK trials new antibody therapy that can stop people who have been exposed to COVID becoming ill, and it could save MILLIONS of lives across the globe
A new antibody treatment with the potential to give people instant immunity after being exposed to Covid-19 and prevent illness is being trialled by scientists in the UK. The drug would offer immediate and long-term protection to patients when it would be too late to offer a vaccine, potentially saving thousands of lives.
It could be given as an emergency treatment to hospital inpatients, care home residents and university students to help reduce the spread of the virus.
Scientists from the UCLH have begun a second clinical trial named Provent, to examine the use of the antibody for people who may not benefit from vaccines, such as patients with a compromised immune system, or those at increased risk of Covid-19 infection due to factors such as age and existing conditions.
UCLH injected the ten people – including medical staff and university students – as part of the Storm Chaser trial at its new vaccine research centre after the study entered phase three trials on December 2.
Key groups of the trial include healthcare workers, students who live in shared accommodation and patients who have been recently exposed to anyone with Covid-19, as well as those in long-term care, the military and industry staff such as factory workers.
In the first trial, the antibody, known as AZD7442, has been developed by pharmaceutical company AstraZeneca, which has also created a vaccine with Oxford University that is awaiting approval for use by the Medicines and Healthcare products Regulatory Agency (MHRA).
They hope the treatment would provide protection from Covid-19 for between six months to a year.